Author

Ayesha Kiani

New York University, New York, NY;

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Fahad KianiiD· 1 shared Rahima Nayeem· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

2 top collaborators · 1 mutual co-author link

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Fahad KianiORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintNov 12, 2026

A Three-Axis Framework for Therapy Prioritization in MBD4-Deficient Tumors: De-confounded Synthetic Lethality Modeling, Replication-Stress Pharmacology, and PARP1 Trapping Decoupling

Fahad Kiani, Ayesha Kiani, Rahima Nayeem

This paper identifies three therapeutic axes for MBD4-deficient tumors using a multi-layered framework, showing sensitivity to ATR inhibitors and cytidine analogs but not PARP inhibitors.

DOI 10.64898/2026.11.10.765519

humanbulk RNA-seq

𝕏 PostBluesky